Inhaled drug to treat lung bleeding in ventilated cancer patients
Treatments studied
Part of Cancer clinical trials.
This Phase 3 study tests whether inhaled tranexamic acid can reduce lung bleeding (pulmonary hemorrhage) in people with cancer who are on a breathing machine. If you qualify, you may receive the study drug to help stop bleeding in the lungs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re over 18 years old
- You have a blood cancer diagnosis (hematologic malignancy)
- You are currently on a mechanical ventilation machine
- Doctors have confirmed lung bleeding, such as persistently bloody airway secretions or bleeding seen on bronchoscopy
- You can (or your legal representative can) sign informed consent
- No key exclusions apply, like being on 100% oxygen, having certain clot risks, or certain drug allergies
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a computer-assisted vacuum device to remove blood clots from the lungs of people with cancer. It aims to see if this procedure is safe and improves quality of life for those with intermediate-risk pulmonary embolism.
This study tests two ways to give a medicine called tranexamic acid (which helps blood clot) to people who are coughing up blood. One way is through a nebulizer (breathing in a mist), and the other is through an IV (into a vein). The goal is to see which method works better to stop the bleeding.
This study compares two ways of giving tranexamic acid, a medicine that helps blood clot, to stop bleeding in the lungs. One way is through a breathing mist (inhaled), and the other is through a vein (IV). The goal is to see which method works better and is safer for people who are coughing up blood.
This trial tests if a medicine called tranexamic acid can help reduce bleeding during surgery for lung cancer that has spread to the spine. It may be an option if you have a single tumor in your spine and are having separation surgery.
This Phase 3 trial tests whether giving tranexamic acid (a medicine that helps reduce bleeding) around the time of surgery can improve outcomes for people with invasive skin melanoma. It may help reduce surgical bleeding while keeping patients safe.
This trial tests if tranexamic acid (a medicine that helps blood clot) reduces bleeding and bruising during nose reconstruction after skin cancer removal. It is for adults having a specific type of flap repair on their nose.
Hear when a new Pulmonary Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.